What to know about "rebound" in COVID symptoms after taking Paxlovid
CBSN
Scientists and federal agencies say they are investigating reports of Americans who say they faced a resurgence of COVID-19 soon after finishing off a course of Paxlovid, Pfizer's antiviral treatment for the disease.
Often referred to as a "rebound" or "relapse" of COVID-19 after taking the standard five days of Paxlovid pills, experts say key questions need to be answered around why it happens, who is being affected, and how doctors should handle the cases.
For example, one report from Veterans Affairs doctors describes a 71-year-old man who saw his COVID-19 symptoms quickly clear up after two days of taking the drug. But four days after finishing the full course of Paxlovid, his symptoms — including a runny nose and sore throat — returned for a few more days.
President Biden on Monday signed into law a defense bill that authorizes significant pay raises for junior enlisted service members, aims to counter China's growing power and boosts overall military spending to $895 billion despite his objections to language stripping coverage of transgender medical treatments for children in military families.
It's Christmas Eve, and Santa Claus is suiting up for his annual voyage from the North Pole to households around the world. In keeping with decades of tradition, the North American Aerospace Command, or NORAD, will once again track Santa's journey to deliver gifts to children before Christmas 2024, using an official map that's updated consistently to show where he is right now.
An anti-money laundering law called the Corporate Transparency Act, or CTA, appears to have been given new life after an appeals court on Monday determined its rules can be enforced as the case proceeds. The law requires small business owners to register with the Financial Crimes Enforcement Network, or FinCEN, by Jan. 1, or potentially pay fines of up to $10,000.